AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Nektar Therapeutics

$38.87 -$4.55 (-10.48%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$39.18
Day Range
$38.00$39.30
Year Range
$33.40$109.00
Market Cap
1.12B
AVG Volume
1.1M
Trailing/Forward PE
-5.8/-
PEG ratio
0.31
Dividend Yield
-
Next Earnings Date
2026-11-12
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
025M50M75M100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NKTR Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q254.59M
26 Q155.63M
25 Q455.23M
25 Q362.6M
25 Q274.93M
25 Q187.25M
24 Q498.43M
24 Q393.14M
24 Q293.16M
24 Q190.17M
Net Income (USD) · TTM
-200M-150M-100M-50M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NKTR Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-157.13M
26 Q1-158.1M
25 Q4-164.08M
25 Q3-120.74M
25 Q2-122.27M
25 Q1-133.04M
24 Q4-118.96M
24 Q3-168.3M
24 Q2-177.08M
24 Q1-175.84M
Operating Income (USD) · TTM
-200M-150M-100M-50M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
NKTR Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-131.22M
26 Q1-125.11M
25 Q4-131.39M
25 Q3-97.95M
25 Q2-100.76M
25 Q1-114.31M
24 Q4-105.2M
24 Q3-153.06M
24 Q2-163.58M
24 Q1-164.4M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: NKTR

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 12 Nov 2026.

Nektar Therapeutics
NKTR
Stockpicker

Video analysis: NKTR

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: NKTR

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.